Breaking News

LSPedia Appoints Erin Parsons as Director of Compliance

Parsons will direct compliance strategy, shape operational best practices, enhance regulatory oversight, and mentor future leaders.

LSPedia, a global provider of serialization, traceability and supply chain solutions in the pharmaceutical, healthcare, and consumer products industries, has appointed Erin Parsons as Director of Compliance.

At LSPedia, Parsons will direct compliance strategy, shape operational best practices, enhance regulatory oversight, and mentor future leaders as the company continues to set the standard for innovation and excellence in pharmaceutical supply chain compliance.

Experience

Parsons joins LSPedia following a 16-year career at Rite Aid, where she advanced from Pharmacy Intern to Director, Pharmacy Compliance & Inventory. In her most recent role, she spearheaded pharmacy compliance initiatives, drug inventory strategy, and developed training programs while managing cross-functional teams and driving operational efficiency.

With expertise in compliance and regulatory strategy, operations and inventory management, and cross-functional leadership, Parsons brings a proven track record of aligning compliance excellence with patient care. She led teams overseeing Quality Assurance, Technician Certification, pharmacy training program development, drug inventory compliance, and centralized controlled substance ordering—all while ensuring adherence to federal and state regulations across Rite Aid’s pharmacy network.

“My passion for compliance, patient safety, and operational excellence has guided my career, allowing me to build trust, foster meaningful relationships and drive impactful results,” said Parsons. “I look forward to leveraging this experience to support LSPedia and its customers. OneScan is not only a compliance solution, OneScan is not only a compliance solution—it also improves operational efficiency while maintaining strict standards under the FDA and State Board of Pharmacy requirements.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters